Search research articles
Contact Us
Filters
Showing results (711-720 of 728) with videos related to
Page
of 73
Sort By:
Journal of Cancer Policy
|
January 14, 2026
Defining the Role and Competencies of the Medical Oncologist in Diagnostic and Therapeutic Care Pathways: Consensus Recommendations from the Italian Association of Medical Oncology (AIOM)
Rossana Berardi, Francesca Rossi, Valentina Tarantino, et al.
Nature Neuroscience
|
June 6, 2023
Psychedelics promote plasticity by directly binding to BDNF receptor TrkB
Rafael Moliner, Mykhailo Girych, Cecilia A Brunello, et al.
Bone Marrow Transplantation
|
April 13, 2022
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01
Francesca Bonifazi, Chiara Pavoni, Jacopo Peccatori, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 15, 2023
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)
Emanuela Palmerini, Marco Gambarotti, Antoine Italiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2021
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study
Bruno Vincenzi, Andrea Napolitano, Marta Fiocco, et al.
ESMO Open
|
January 21, 2026
International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized disease
C Giani, G G Baldi, S Ljevar, et al.
Blood Cancer Discovery
|
July 11, 2025
Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma
Mireia Uribe-Herranz, Aina Oliver-Caldés, Neus Martínez-Micaelo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2026
Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium
Giacomo G Baldi, Claudia Giani, Silva Ljevar, et al.
ESMO Open
|
September 12, 2024
Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group
C Giani, R A Denu, S Ljevar, et al.
JAMA Oncology
|
May 26, 2018
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series
Anna Maria Frezza, Robin L Jones, Salvatore Lo Vullo, et al.
Page
of 73
Search research articles
Search
Showing results (711-720 of 728) with videos related to
Sort By:
Page
of 73
Journal of Cancer Policy
|
January 14, 2026
Defining the Role and Competencies of the Medical Oncologist in Diagnostic and Therapeutic Care Pathways: Consensus Recommendations from the Italian Association of Medical Oncology (AIOM)
Rossana Berardi, Francesca Rossi, Valentina Tarantino, et al.
Nature Neuroscience
|
June 6, 2023
Psychedelics promote plasticity by directly binding to BDNF receptor TrkB
Rafael Moliner, Mykhailo Girych, Cecilia A Brunello, et al.
Bone Marrow Transplantation
|
April 13, 2022
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01
Francesca Bonifazi, Chiara Pavoni, Jacopo Peccatori, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 15, 2023
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)
Emanuela Palmerini, Marco Gambarotti, Antoine Italiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2021
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study
Bruno Vincenzi, Andrea Napolitano, Marta Fiocco, et al.
ESMO Open
|
January 21, 2026
International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized disease
C Giani, G G Baldi, S Ljevar, et al.
Blood Cancer Discovery
|
July 11, 2025
Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma
Mireia Uribe-Herranz, Aina Oliver-Caldés, Neus Martínez-Micaelo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2026
Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium
Giacomo G Baldi, Claudia Giani, Silva Ljevar, et al.
ESMO Open
|
September 12, 2024
Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group
C Giani, R A Denu, S Ljevar, et al.
JAMA Oncology
|
May 26, 2018
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series
Anna Maria Frezza, Robin L Jones, Salvatore Lo Vullo, et al.
Page
of 73